Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The cardiovascular system ensures the delivery of oxygen and nutrients to all cells, tissues, and organs. Under extended exposure to reduced oxygen levels, cells are able to survive through the transcriptional activation of a series of genes that participate in angiogenesis, glucose metabolism, and cell proliferation. The oxygen-sensitive transcriptional activator HIF-1 (hypoxia-inducible factor-1) is a key transcriptional mediator of the response to hypoxic conditions. The HIF-1 pathway was found to be a master regulator of angiogenesis. Whether the process is physiological or pathological, HIF-1 seems to participate in vasculature formation by synergistic correlations with other proangiogenic factors such as VEGF (vascular endothelial growth factor), PlGF (placental growth factor), or angiopoietins. Considering the important contributions of HIF-1 in angiogenesis and vasculogenesis, it should be considered a promising target for treating ischaemic diseases or cancer. In this review, we discuss the roles of HIF-1 in both physiological/pathophysiological angiogenesis and potential strategies for clinical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of HIF-α gene structures and DNA binding. (a) HIF-1α and HIF-2α contain the following domains: a nuclear localisation domain (NLS), DNA binding and dimerisation domains (bHLH/PAS), oxygen-dependent degradation domain (ODDD), and cofactor interaction and transcriptional activity domains (N-TAD/C-TAD). HIF-3α lacks a C-TAD domain. NLS: nuclear localisation signal; bHLH: basic helix-loop-helix domain; PAS: Per-ARNT-Sim motif; ODDD: oxygen-dependent degradation domain; N-TAD: N-terminal transactivation domain; C-TAD: C-terminal transactivation domain. (b) Dimerisation of HIF-1α with HIF-1β under hypoxic conditions results in the formation of the HIF-1 transcription factor, which binds to hypoxia response elements (HREs) and activates the transcription of O2-dependent genes (according to [134]).](https://figures.cochat.ai/paper-figures/7f1eff6f4e4b425f9d8561e5e5c9be64/hypoxia-inducible-factor-1-in-physiological-and-pathophysiological-angiogenesis-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the normal developmental setting, HIF-1α plays a dominant role throughout vasculogenesis, whereas HIF-2α contributes primarily to vessel remodeling and maturation during the later stages of vasculogenesis (the HIF switch) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Characteristics of tumor vasculature include lack of stabilization by pericytes and smooth muscle cells and a lack of an arterial or venous phenotype that leads to leakage, poor blood flow and perfusion (Figure 3) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 2×
“Because the uterine environment is hypoxic it is thereby obvious that hypoxiamay be the primary stimulus of vessel formation [3, 4].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276 · cited 1×
“growth factors that activate their receptors [5, 6].”
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“Vessel formation occurs via only two basicmechanisms: vasculogenesis and angiogenesis [2].”
BackgroundActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Research works printed but not linked: 1
- Folkman J. Holland J. F. Bast R. C. Jr. Morton D. L. Frei E. III Kufe D. W. Weichselbaum R. R. Tumour angiogenesis Cancer Medicine 1997 Baltimore, Md, USA Williams & Wilkins 181 204
Cited by
Items 201–300 of 650
DNA methylation landscape in pregnancy-induced hypertension: progress and challenges
Deng, F., Lei, J., Qiu, J., Zhao, C., Wang, X., Li, M., Sun, M., Zhang, M., & Gao, Q. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01248-0 · Cited by 25
“The HIF1 pathway has been identified as a master regulator of angiogenesis and is involved in vasculature formation through synergistic interactions with other proangiogenic factors such as vascular endothelial growth factor (VEGF), placental growth factor (PlGF), and angiopoietins [129].”
Advances in Research on Stem Cell-Based Pulp Regeneration
Lee, H.-N., Cheng, L., Liao, L., & Tian, W. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00389-2 · Cited by 25
“Furthermore, cytokines that induce pulp angiogenesis are also helpful for the survival of stem cell transplants [23, 24].”
BackgroundClassification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
Handley, K. F., Sims, T. T., Bateman, N. W., Glassman, D., Foster, K. I., Lee, S., Yao, J., Yao, H., Fellman, B. M., Liu, J., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.36626 · Cited by 27
Zhong, Y.-L., Wang, P.-Q., Hao, D.-L., Sui, F., Zhang, F., & Li, B. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i1.36 · Cited by 25
The mTOR signalling in corneal diseases: A recent update
Li, X., Chen, K., Wang, Z., Li, J., Wang, X., Xie, C., Tong, J., & Shen, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115620 · Cited by 25
Mammadzada, P., Gudmundsson, J., Kvanta, A., & André, H. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13119 · Cited by 28
“It has been shown that regulation of factors as a response to hypoxia is mainly driven by hypoxia-inducible factor (HIF) molecules (Zimna & Kurpisz 2015).”
BackgroundZarkesh, I., Halvaei, M., Ghanian, M. H., Bagheri, F., Sayahpour, F. A., Azami, M., Mohammadi, J., Baharvand, H., & Eslaminejad, M. B. (2019) · Biofabrication · doi:10.1088/1758-5090/ab51ae · Cited by 25
Hsu, H., Ko, P., Wu, H., Lin, H., Wang, C., & Tung, Y. (2021) · Small · doi:10.1002/smll.202006091 · Cited by 25
Alherz, F. A., El-Masry, T. A., Oriquat, G. A., Elekhnawy, E., Al‐Shaalan, N. H., Gaballa, M. M. S., Zahaby, E. I. E., & El‐Nagar, M. M. F. (2024) · Pharmaceuticals · doi:10.3390/ph17091144 · Cited by 26
“For every chemical employed in this investigation, the highest analytical grade was utilized.”
MethodmTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
Yang, J. Y., Madrakhimov, S. B., Ahn, D. H., Chang, H. S., Jung, S. J., Nah, S. K., Park, H. Y., & Park, T. K. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0380-0 · Cited by 25
Qu, G., & Li, B. (2019) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_77_17 · Cited by 24
“It is reported in the literature that high HIF‐1α expression in the tumor can promote angiogenesis through upregulating VEGF.([34]) The application of Rg3 leads to the gradual decrease of VEGF expression, which is closely associated with HIF‐1α expression, as is found in this experiment.”
Lin, Y., Liu, H., & Wang, X. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4662 · Cited by 26
The Role of Tinzaparin in Oncology
Dimakakos, E. P., Vathiotis, I. A., & Syrigos, K. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617729215 · Cited by 24
“Other mechanisms, such as the Warburg effect (a shift to anaerobic glucose metabolism, causing an increase in lactate and pyruvate concentrations), implicated in the induction of HIF-1-dependent angiogenesis.(86) On the other hand, HIF-1independent mechanisms of angiogenesis in patients with cancer involve multiple RA…”
BackgroundSinking Our Teeth in Getting Dental Stem Cells to Clinics for Bone Regeneration
Shoushrah, S. H., Transfeld, J. L., Tonk, C. H., Büchner, D., Witzleben, S. T., Sieber, M. A., Schulze, M., & Tobiasch, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126387 · Cited by 23
The WWOX/HIF1A Axis Downregulation Alters Glucose Metabolism and Predispose to Metabolic Disorders
Baryła, I., Styczeń-Binkowska, E., Płuciennik, E., Kośla, K., & Bednarek, A. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063326 · Cited by 23
“This is followed by changes in cell differentiation and tissue remodeling [10].”
BackgroundCollaborative Design of MgO/FeOx Nanosheets on Titanium: Combining Therapy with Regeneration
Zhang, D., Tan, J., Xu, R., Du, H., Xie, J., Peng, F., & Liu, X. (2022) · Small · doi:10.1002/smll.202204852 · Cited by 23
Hedayati, N., Aghdam, Z. B., Rezaee, M., Dehmordi, R. M., Alimohammadi, M., & Mafi, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673259378231031061149 · Cited by 24
The Janus face of HIF-1α in ischemic stroke and the possible associated pathways
Amin, N., Abbasi, I. N., Wu, F., Shi, Z., Sundus, J., Badry, A., Yuan, X., Zhao, B., Pan, J., Mi, X., et al. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105747 · Cited by 25
Deng, M., Zha, J., Zhao, H., Jia, X., Shi, Y., Li, Z., Fu, G., Yu, L., Fang, Z., & Xu, B. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111934 · Cited by 25
Linton, A. E., Weekman, E. M., & Wilcock, D. M. (2021) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2021.100030 · Cited by 22
“2, assists in the maturation and differentiation of newly formed vessels and the lumen diameter expands forming a complete vessel [[30], [113]], [174].”
BackgroundInfluentialFootprints of microRNAs in Cancer Biology
Rajasegaran, Y., Azlan, A., Rosli, A. A., Yik, M. Y., Khor, K. Z., Yusoff, N. M., & Moses, E. J. (2021) · Biomedicines · doi:10.3390/biomedicines9101494 · Cited by 22
Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
Cao, M., Wang, Y., Lu, G., Qi, H., Li, P., Dai, X., & Lü, J. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100305 · Cited by 23
“Under hypoxia, HIF-1 could significantly upregulate the expression of VEGF [20,21].”
BackgroundHe, R., Jin, Z., Ma, R., Hu, F., & Dai, J. (2020) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2020.12.005 · Cited by 22
Hypoxia induces the dysfunction of human endothelial colony-forming cells via HIF-1α signaling
He, M., Ma, S., Cai, Q., Wu, Y. H., Shao, C.-J., Kong, H., Wang, H., Zeng, X., & Xie, W. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.09.013 · Cited by 22
β-Hydroxybutyrate Facilitates Postinfarction Cardiac Repair via Targeting PHD2
Wang, C., Xu, W., Jiang, S., Wu, Y., Shu, J., Gao, X., & Huang, K. (2025) · Circulation Research · doi:10.1161/circresaha.124.325179 · Cited by 22
Wang, J., Tian, Q., Liu, Y., Cai, C., Fu, S., Li, J., Guan, Y., Liao, X., Su, D., Sun, T., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02414-7 · Cited by 22
CRISPR Technology for Ocular Angiogenesis
Chung, S. H., Sin, T.-N., Ngo, T., & Yiu, G. C. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.594984 · Cited by 21
Decreasing mitochondrial fission ameliorates HIF-1α-dependent pathological retinal angiogenesis
Huang, S.-Q., Cao, K., Wang, C., Chen, P.-L., Chen, Y., Zhang, Y., Yu, S., Bai, Z.-X., Guo, S., Liao, M., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01262-3 · Cited by 21
Pharmacological interventions for intraplaque neovascularization in atherosclerosis
Ugusman, A., Hisam, N. S. N., Othman, N. S., Anuar, N. N. M., Hamid, A. A., Kumar, J., Razmi, M. M., & Aminuddin, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108685 · Cited by 23
Chen, J., Zhang, M., Ma, Z., Yuan, D., Zhu, J., Tuo, B., Li, T., & Liu, X. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00604-1 · Cited by 23
Doğanlar, O., Doğanlar, Z. B., Delen, E., & Doğan, A. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101617 · Cited by 21
Bouhamida, E., Morciano, G., Pedriali, G., Ramaccini, D., Tremoli, E., Giorgi, C., Pinton, P., & Patergnani, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311105 · Cited by 20
Palomo, A. O., Quiñonero, F., Ortíz, R., Sarabia, F., Prados, J. C., & Melguizo, C. (2024) · Marine Drugs · doi:10.3390/md22030101 · Cited by 20
“In this regard, this compound was associated with downregulation of MMP-2 and MMP-9, related to cell invasion [18], and HIF-1 α and VEGF, related to angiogenesis [19].”
BackgroundPeptide therapeutics that directly target transcription factors
Inamoto, I., & Shin, J. A. (2018) · Peptide Science · doi:10.1002/pep2.24048 · Cited by 22
Mu, Y., Yu, H., Wu, T., Zhang, J., Evans, S. Μ., & Chen, J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008730 · Cited by 20
“Since the oxygen-sensitive transcriptional activator hypoxia-inducible factor-1 (HIF-1) is a key transcriptional mediator of angiogenesis related genes including Angpt1 [23], and cardiomyocyte specific knockout of HIF-1α in mouse leads to embryonic lethality [24], we performed immunostaining to check the exrepssion le…”
BackgroundCubillos‐Zapata, C., Martínez‐García, M. Á., Díaz‐García, E., Toledano, V., Campos‐Rodríguez, F., Sánchez‐de‐la‐Torre, M., Nagore, E., Martorell, A., Blasco, L., Pastor, E., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001247rr · Cited by 20
“Ulceration 13 (10) 23 (21) 15 (21) 12 (25) .”
Li, M., Qi, Z., Zhang, J., Zhu, K., & Wang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.634611 · Cited by 20
Devaux, C. A., & Raoult, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.960308 · Cited by 21
Abdul, K. S. M., Jovanović, S., & Jovanović, A. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13064 · Cited by 20
Hypoxia triggers angiogenesis by increasing expression of LOX genes in 3-D culture of ASCs and ECs
Xie, Q., Xie, J., Tian, T., Ma, Q., Zhang, Q., Zhu, B., & Cai, X. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.011 · Cited by 20
McDermott, A., & Tavassoli, A. (2024) · Transcription · doi:10.1080/21541264.2024.2417475 · Cited by 20
An, M., Yan, J., Liu, B., & Liu, Q. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0023 · Cited by 20
“At the molecular level, hypoxia-inducible factor (HIF) signaling induced by hypoxia up-regulates pro-angiogenic factors and weakens the interaction between immune cells and the vascular wall, thereby diminishing immune infiltration [ 74 , 75 ].”
Li, Y., Jing-Ping, G. E., Ke, M. A., Yuan-Yuan, Y. I. N., He, J., & Jian-Ping, G. U. (2022) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(22)60172-9 · Cited by 21
Opichka, M. A., Livergood, M. C., Balapattabi, K., Ritter, M. L., Brozoski, D., Wackman, K. K., Lu, K., Kozak, K. N., Wells, C. W., Fogo, A. B., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg8118 · Cited by 19
“In contrast, the protein content of VEGFA, a well-recognized HIF1 target ( 57 , 58 ), and its homolog, PlGF ( 59 ), were unchanged in labyrinth-enriched placentas (fig.”
BackgroundSun, Y., Hsu, C., Ling, T., Liu, L., Lin, T.-C., Jakfar, S., Young, I.-C., & Lin, F. (2020) · Biofabrication · doi:10.1088/1758-5090/ab78ee · Cited by 20
The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis
Rahat, M. A., Safieh, M., Simanovich, E., Pasand, E., Gazitt, T., Haddad, A., Elias, M., & Zisman, D. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02333-6 · Cited by 19
“Hypoxia increases the expression of many proangiogenic factors, such as vascular endothelial growth factor (VEGF) [6], which is also a strong chemoattractant for macrophages [7].”
BackgroundLu, Y., Yang, Y., Zhang, J., Zhang, H., Ma, C., Tang, X., Wu, J., Li, L., Wei, J., Chen, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649591 · Cited by 19
PPARγ Agonists: Emergent Therapy in Endometriosis
Vallée, A., Vallée, J.-N., Blanche, A. F. L., & Lecarpentier, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14060543 · Cited by 19
“Several signaling pathways are implicated in angiogenesis initiation [93].”
BackgroundWei, S., Chen, T., Kao, F., Hsu, Y.-J., & Chen, Y. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221084096 · Cited by 19
COVID-19, Vascular Endothelial Growth Factor (VEGF) and IodidePreprint
Turkia, M. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3604987 · Cited by 23
Divergent landscapes of A-to-I editing in postmortem and living human brain
Santos, M. R. D. L., Kopell, B. H., Grice, A. B., Ganesh, G., Yang, A., Amini, P., Liharska, L. E., Vornholt, E., Fullard, J. F., Dong, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49268-z · Cited by 18
Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas
Irimia, R. M., & Piccaluga, P. P. (2024) · Cancers · doi:10.3390/cancers16193359 · Cited by 21
“The main regulator of angiogenesis is hypoxia factor 1 alpha (HIF-1 α ) via the secretion of pro-angiogenic cytokines [33].”
BackgroundSun, X., Zhang, Y., Li, B., & Yang, H. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1531887 · Cited by 18
“VEGF is regarded as the most crucial proangiogenic factor [18,31].”
BackgroundSegarra-Medrano, A., Martín, M., Agraz, I., Vilaprinyó, M., Chamoun, B., Escalante, E. J., Molina, M., Campàs, L. C., García-Carrasco, A., & Roche, S. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz105 · Cited by 18
Ornell, K. J., Mistretta, K. S., Newman, E. A., Ralston, C. Q., & Coburn, J. M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01267 · Cited by 18
Melatonin as a potential inhibitor of kidney cancer: A survey of the molecular processes
Dana, P. M., Reiter, R. J., Hallajzadeh, J., Asemi, Z., Mansournia, M. A., & Yousefi, B. (2020) · IUBMB Life · doi:10.1002/iub.2384 · Cited by 22
“, VEGF and angiopoietins) is involved in the formation of vasculature both in physiological and pathological conditions.(72) HIF-1 regulation can be influenced by different factors, such as genetic alterations, activation of oncogenes, carcinogens, growth factors, and stress activators.”
BackgroundBoehme, J. B., Morris, C. J., Chiacchia, S., Gong, W., Wu, K. Y., Kameny, R. J., Raff, G. W., Fineman, J. R., Maltepe, E., & Datar, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-020-80882-1 · Cited by 18
Nguyen, A., Moussallieh, F., Mackay, A. G., Çiçek, A. E., Coca, A. H., Chenard, M. P., Weingertner, N., Lhermitte, B., Letouzé, É., Guérin, É., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16500 · Cited by 18
“It also suggests that HIF-2α can modulate proliferation even at low levels of expression, but it may depend on a complex transcriptional synergy with HIF-1α [15, 19, 21, 51].”
BackgroundEndocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development
Marinello, W. P., & Patisaul, H. B. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.04.003 · Cited by 21
Chemical Hypoxia Induces Pyroptosis in Neuronal Cells by Caspase-Dependent Gasdermin Activation
Park, C. H., Park, J. Y., & Cho, W. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042185 · Cited by 17
“Upon apoptotic stimuli, Bax and Bak are activated and trigger mitochondrial outer membrane permeabilization (MOMP) that leads to the release of proapoptotic proteins, including cytochrome c, from the mitochondrial intermembrane space into the cytoplasm.”
BackgroundMethodLi, K., & He, C. (2019) · BioMed Research International · doi:10.1155/2019/6317015 · Cited by 19
“HIF-1A acts as the main regulator of homeostasis in hypoxic cells by activating the transcription of various genes, including those involved in energymetabolism [8, 9], angiogenesis [10, 11], and apoptosis [12, 13], as well as other genes involved in increasing oxygen delivery or promoting metabolism under hypoxic con…”
BackgroundPreda, M. B., Lupan, A., Neculachi, C. A., Leti, L.-I., Fenyo, I. M., Popescu, S., Nastase-Rusu, E.-G., Marinescu, C. I., Simionescu, M., & Burlacu, A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15717 · Cited by 18
The insights into molecular pathways of hypoxia‐inducible factor in the brain
Ostrowski, R. P., & Zhang, J. H. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24366 · Cited by 18
Zhu, M., Yang, M. S., Yang, Q., Liu, W., Geng, H., Li, P., Wang, L., Ge, R., Ji, L., Cui, S., et al. (2020) · BioMed Research International · doi:10.1155/2020/9204708 · Cited by 17
“Sustained hypoxia exposure triggers subsequent vascular pathologic changes such as an increase in blood viscosity and angiogenesis leading to BM degradation [7, 8, 10, 38].”
BackgroundZhang, J., Su, Y., Wang, X., Yao, X., & Du, J. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.2001 · Cited by 17
Vascular therapy for Duchenne muscular dystrophy (DMD)
Thapa, S., Elhadidy, S., & Asakura, A. (2023) · Faculty Reviews · doi:10.12703/r/12-3 · Cited by 18
Human ESC-derived vascular cells promote vascular regeneration in a HIF-1α dependent manner
Lei, J., Jiang, X., Huang, D., Jing, Y., Yang, S., Geng, L., Yan, Y., Zheng, F., Cheng, F., Zhang, W., et al. (2023) · Protein & Cell · doi:10.1093/procel/pwad027 · Cited by 16
Foresto‐Neto, O., da Silva, A. R. P. A., Cipelli, M., Santana, F. P. R., & Câmara, N. O. S. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.012 · Cited by 17
“Both HIF-1α and HIF-2α regulate physiological and pathological angiogenesis [30,31] and also regulate specific target genes.”
BackgroundFan, J., Yuan, X., Lu, T., & Ye, J. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01420 · Cited by 17
Wicaksono, S., Nugraha, A. P., Rahmahani, J., Rantam, F. A., Kuncorojakti, S., Susilowati, H., Riawan, W., Arundina, I., Lestari, P., Masya, R. N., et al. (2023) · European Journal of Dentistry · doi:10.1055/s-0043-1761192 · Cited by 18
“26 In addition, miRNA-23a can increase vascular permeability and cell migration which is crucial in angiogenesis.”
BackgroundHypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
Li, W., Zhao, Y., & Fu, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00259 · Cited by 16
Houri, A., Mukudai, Y., Abe, Y., Watanabe, M., Nara, M., Miyamoto, S., Kurihara, M., Shimane, T., & Shirota, T. (2023) · Oncology Reports · doi:10.3892/or.2023.8520 · Cited by 15
“Several previous studies (3,5,6,37,40,51) have found that tumor cells induce various transcription factors, including HIF‑1 α , to adapt to hypoxia, resulting in induced angiogenesis ( i.e., formation of new blood vessels to prevent hypoxic conditions).”
Özcan, M. S., Savran, M., Doğuç, D. K., Doğan, H. K., Altıntaş, M., & Coşan, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24007 · Cited by 15
“1) [17].”
Advances in tumor vascular growth inhibition
Zhang, K., Shi, Y., Jin, Z., & He, J. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03432-5 · Cited by 15
“As tumor growth and metastasis are heavily influenced by neovascularization, effectively inhibiting this process can play a pivotal role in suppressing tumor progression and growth [20].”
Cuproptosis nanomedicine in cancer therapy: Novel insights and future perspectives
Wang, L., Piao, J., Qi, H., Qiao, C., Guo, Q., Wei, M., & Li, Z. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216284 · Cited by 15
Zhang, Z., Wang, D., Xu, R., Li, X., Wang, Z., & Zhang, Y. (2024) · Biomolecules · doi:10.3390/biom14121592 · Cited by 16
“Zimna and Kurpisz found that HIF-1 α promotes VEGF expression, facilitating new blood vessel formation and improving blood supply in hypoxic areas [54].”
Zhao, L., Zhao, J., Gao, R., Tian, Y., Zhang, Y., Tang, W., Jiang, Y., Li, C., Wang, M., Yang, F., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109783 · Cited by 15
Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R
Zhang, H., Liu, Y., Cheng, L., Ma, X., & Luo, X. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.008 · Cited by 16
Kim, E., Kim, S., Na, H., Han, W., Kim, N., Suh, Y., & Surh, Y. (2021) · Cells · doi:10.3390/cells10030526 · Cited by 17
“In contrast, the most important transcription factor responsible for hypoxia-induced generation of VEGF is HIF-1 [83].”
Zhu, M., Ma, Y., Tang, M., Pan, L., & Liu, W. (2022) · Physiological Research · doi:10.33549/physiolres.934930 · Cited by 15
Kim, N., Ko, Y., Shin, Y., Park, J., Lee, A. J., Kim, K. W., & Pyo, J. (2023) · Biology · doi:10.3390/biology12070970 · Cited by 15
“Consequently, this angiogenesis process facilitates the supply of oxygen and nutrients to the tumor [3].”
BackgroundInfluentialEnhanced angiogenesis in the 3D dynamic responsive implant for inguinal hernia repair ProFlor
Amato, G., Puleio, R., Rodolico, V., Agrusa, A., Calò, P. G., Buono, G. D., Romano, G., & Goetze, T. O. (2021) · Artificial Organs · doi:10.1111/aor.13926 · Cited by 15
The role of hypoxic microenvironment in rheumatoid arthritis
Zheng, Q.-H., Zhai, Y., Wang, Y.-H., & Pan, Z. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1633406 · Cited by 19
“Under hypoxia, VHL is disabled, unable to recognize and hydrolyze HIF, resulting in a signi fi cant accumulation of HIF, which makes VHL and HIF cooperate, further amplifying the effect, promoting the proliferation and migration of vascular endothelial cells and inducing angiogenesis (41).”
Zamanian, M. Y., Turkadze, K. A., Ivraghi, M. S., Golmohammadi, M., Sharifi, M., & Amlashi, Z. K. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70829 · Cited by 17
Effect of Metformin on HIF-1α Signaling and Postoperative Adhesion Formation
Biller, M., Tuffs, C., Bleul, M., Tran, D. T.-A., Dupovac, M., Keppler, U., Harnoss, J. M., Probst, P., Schneider, M. A., & Strowitzki, M. J. (2022) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000205 · Cited by 14
Pitale, P. M., Shen, G., Sigireddi, R. R., Polo-Prieto, M., Park, Y. H., Gibson, S. E., Westenskow, P. D., Channa, R., & Frankfort, B. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1073786 · Cited by 14
“Upregulation of HIF1α/VEGFα signaling is known to cause increased capillary development (Ramakrishnan et al., 2014; Zimna and Kurpisz, 2015).”
BackgroundEffects of natural products on angiogenesis in melanoma
Wang, X., Liu, E., Hou, C., Wang, Y., Zhao, Y., Guo, J., & Li, M. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106100 · Cited by 14
Dumitru, C. Ș., & Raica, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168855 · Cited by 15
“For example, hypoxia, a common feature of the tumor microenvironment, activates hypoxia-inducible factor-1 (HIF-1), which in turn can modulate VEGF splicing to favor the production of pro-angiogenic isoforms [37].”
BackgroundLv, W., Yang, F., Ge, Z., Xin, L., Zhang, L., Zhai, Y., Liu, X., Guo, Q., Mao, X., Luo, P., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107807 · Cited by 14
“VEGF is a key responding molecule to hypoxia (31), which plays critical roles in vasculogenesis during embryonic stages and angiogenesis in adults (32).”
BackgroundNew insights into the role of ubiquitination in angiogenesis (Review)
Chen, T., Wang, K., & Sun, Z. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5473 · Cited by 14
Vageli, D. P., Doukas, P. G., Georgiou, D., Prokopiou, M. P., Ladaki, N. E., Papadopoulou, A., Doukas, S. G., Zacharouli, K., Makaritsis, K. P., & Ιωάννου, Μ. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27004 · Cited by 14
Assessing the protective effects of cryptotanshinone on CoCl2‑induced hypoxia in RPE cells
Gu, Y., Liu, W., Liu, G., Li, X., & Lu, P. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12379 · Cited by 17
Ortega, M. A., Sáez, M. A., Fraile‐Μartinez, O., Álvarez-Mon, M. Á., Montero, C. G., Guijarro, L. G., Asúnsolo, Á., Álvarez‐Mon, M., Buján, J., García‐Honduvilla, N., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.65419 · Cited by 15
“Likewise, 52 control women with no presence of CVD (HC) were studied, with a median age of 34 [27-41] years and a median gestational time of 41 [39-42] weeks for all clinical and histological studies.”
BackgroundMethodWang, J., Zhang, A., Li, Y., Xu, J., Huang, F., Zhao, M., Wu, B., & He, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29019 · Cited by 14
“Hypoxia‐inducible factor (HIF) is considered to be a critical factor in cell hypoxia.(10) HIF‐1α is a nuclear transcription factor involved in the transcription of a variety of genes under hypoxic conditions, including endothelin‐1 (Knowles 2005), vascular endothelial growth factor (VEGF),(10) erythropoietin,(11) plat…”
BackgroundAgamia, N., Sorror, O. A., Sayed, N. M. E., Ghazala, R. A., Echy, S. M., Moussa, D. H., & Melnik, B. C. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02594-6 · Cited by 14
“HIF-1 is a master regulator of angiogenesis and participates in vasculature formation by synergistic correlations with other proangiogenic factors including VEGF [60].”
BackgroundBekkering, I., Leeuwerke, M., Tanis, J. C., Schoots, M. H., Verkaik‐Schakel, R. N., Plösch, T., Bilardo, C. M., Eijsink, J. J. H., Bos, A. F., & Scherjon, S. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221972 · Cited by 14
CXCL10 promotes melanoma angiogenesis and tumor growth
Kim, B.-J., Park, Y.-Y., & Lee, J. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2402024 · Cited by 13
“Angiogenesis is hyperactivated by the over-expression of pro-angiogenic factors and the inactivation of anti-angiogenic factors in the microenvironment of several malignant tumors (Khosravi Shahi et al. 2009; Hall et al. 2015; Zimna and Kurpisz 2015; Pandita et al. 2021).”
BackgroundFSTL-1 as a Novel Cardiokine of Cardiac Angiogenesis: A Systematic Review
Karisa, P., Sylviana, N., Fitria, N., & Setiawan, I. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s509482 · Cited by 15
“14 Hypoxic conditions can stimulate the release of HIF-1, so many studies state that the process of cardiac angiogenesis depends on oxygen or hypoxia, or also called the HIF-1-dependent pathway.”
Shao, N., Han, Y., Song, L., & Song, W. D. (2020) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_781_19 · Cited by 13
Bao, M., Shang, F., Liu, F., Hu, Z., Wang, S., Yang, X., Yu, Y., Zhang, H., Jiang, C., Jiang, J.-L., et al. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-01008-6 · Cited by 14
Metadata
- Authors
- Zimna, A., & Kurpisz, M.
- Affiliations
- Institute of Human Genetics (PL)
- Corresponding author
- Kurpisz, Maciej
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4471260
- OpenAlex
- W1597158509
- Cited by
- 604
- References
- 138
- Citations by year
- 2026: 40 · 2025: 66 · 2024: 88 · 2023: 78 · 2022: 67 · 2021: 79 · 2020: 64 · 2019: 45 · 2018: 22 · 2017: 28 · 2016: 23 · 2015: 3
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Centre, Poland (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- National Centre for Research and Development (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, angiogenesis, hypoxia, vascular endothelial growth factor, placental growth factor, angiopoietins, vasculogenesis, ischemic diseases, cancer, oxygen sensing, transcriptional regulation
- MeSH terms
- Placenta Growth Factor, Hypoxia, Humans, Neovascularization, Pathologic, Pregnancy Proteins, Transcriptional Activation, Cell Hypoxia, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.